Previous 10 | Next 10 |
Ironwood Pharma (IRWD) announced that Mark Mallon plans to step down as its chief executive officer and a member of the company's Board effective March 12, 2021.The company has named Thomas McCourt, its president, as interim CEO upon Mallon’s exit.Ironwood plan...
– Mark Mallon to step down as CEO; Board appoints Thomas McCourt as interim CEO – – Julie McHugh to become Executive Chair of the Board of Directors – Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare compa...
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its fourth quarter and full year 2020 investor update conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, February 17, 2021. Individuals interested in participating in the call should dial (83...
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, will provide a corporate overview during a presentation and Q&A session at the 39 th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 5:20 p.m. Eastern Time. A live web...
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the appointment of Jay P. Shepard to its Board of Directors, effective immediately. Mr. Shepard will also serve as a member of the Audit Committee. Following the appointment of Mr. Shepard, the Board is now composed of 11...
Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2020 Results Earnings Conference Call November 5, 2020, 4:30 PM ET Company Participants Meredith Kaya - Vice President, Investor Relations and Corporate Communications Mark Mallon - Chief Executive Officer Mark Plinio - Chief Commercial Officer Gina Co...
Image source: The Motley Fool. Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Q3 2020 Earnings Call Nov 6, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Trans...
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in a virtual fireside chat at the 29 th Annual Credit Suisse Healthcare Conference on Wednesday, November 11, 2020 at 3:30 p.m. Eastern Time. A live webcast of Ironwood’s fireside chat will be accessible t...
The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Ironwood Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation
Alongside its Q3 results last night, Ironwood Pharmaceuticals (IRWD) announced the appointment of Alexander Denner to the board, effective next week.Dr. Denner is the founder and CIO at Sarissa Capital Management.Board Chair Julie McHugh: "We believe [Denner's] wealth of knowledge will be inv...
News, Short Squeeze, Breakout and More Instantly...
Ironwood Pharmaceuticals Inc. Company Name:
IRWD Stock Symbol:
NASDAQ Market:
Ironwood Pharmaceuticals Inc. Website:
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 8, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) ...
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City. A live webcast of I...
2024-05-22 07:30:10 ET Wells Fargo analyst issues OVERWEIGHT recommendation for IRWD on May 22, 2024 05:13AM ET. The previous analyst recommendation was Overweight. IRWD was trading at $6.78 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...